Par LEXPRESS.fr avec AFP, publié le 11/07/2011 à 17:33, mis à jour à 17:34
The vaccine against cancer of the uterus of flight he presents a risk to health? In a letter to Health Minister Xavier Bertrand, a group of doctors on the island of Reunion is questioning the benefits of the vaccine.
These doctors, led by Dr. Philip Chazournes, president of Med’Océan, are “very concerned about immunization” against cancer of the cervix ‘, essentially based on an unwarranted fear. ”
These doctors, led by Dr. Philip Chazournes, president of Med’Océan, are “very concerned about immunization” against cancer of the cervix ‘, essentially based on an unwarranted fear. “
“Cervical cancer is really a public health problem in France in the sense understood by epidemiologists? The question worth asking, because in reality, there has been since 1980 a steady decline in the number of new cases and mortality from this disease, “they write.
“Now, the only preventive measure associated with this steady decline is the regular screening by Pap test,” said Dr. de Chazournes, noting that “the thousands of women (1067 deaths estimated for 2005) who die each years in France of this cancer are mostly women who were not followed regularly by smear. ”
The group goes further in his criticism and questions the effectiveness of the vaccine Gardasil from Sanofi Pasteur MSD, one of the two vaccines marketed in France and reimbursed by social security.
Gardasil is given as three injections. Each – reimbursed by social security – costs 135 euros.
According to Le Monde, several claims have been sent to the Regional Commission for Conciliation and Compensation Medical (RCCI). In daily life, girls talk about their ordeal since their first injection. “The dizziness, vomiting happen suddenly, every two or three days. I had to leave during” shows Laëtitia. In total, 1700 notifications for Gardasil had been collected by the French Agency for Safety of Health Products (AFSSAPS)
“Conflict of Interest”
In an open letter of June 10, Philippe de Chazournes has also asked Professor Jean-Luc Harousseau, president of the National Authority for Health (HAS), to withdraw the recommendations on cancer screening cervical citing conflicts of interest “major” of some group members who have written.
He appealed to the HAS “to be as fast as possible a new working group, with no major conflicts of interest with industry, to promote cancer screening cervical Pap smear, which by itself would, if properly and regularly in all women involved, to cause the disappearance of mortality from this cancer. ”